Immuno-oncology therapy associated thromboembolic events in metastatic renal cell carcinoma
{{output}}
The relationship between thromboembolic events (TEs) and immune-oncology (IO) agents in patients with metastatic renal cell carcinoma (mRCC) with inferior-vena-cava (IVC) thrombus has not been explored despite conferring significant morbidity. A late 30s femal... ...
